SCHEMBL3971576

SCHEMBL3971576

N#Cc1ncc(Cl)cc1-c1ccccn1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 2/20 0.45
CCR5 P51681 2/20 0.45
CCR8 P51685 2/20 0.45
PTGS1 P23219 1/20 0.44
PTGS2 P35354 1/20 0.44
GRM5 P41594 4/20 0.44
KDM4E B2RXH2 2/20 0.42
POLB P06746 2/20 0.42
ALDH1A1 P00352 1/20 0.42
METAP1 P53582 3/20 0.39
LMNA P02545 1/20 0.39
CYP1A2 P05177 1/20 0.39
BLM P54132 1/20 0.39
HIF1A Q16665 1/20 0.39
DOHH Q9BU89 1/20 0.39
P4HTM Q9NXG6 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
METAP2 P50579 2/20 0.39
CHEK1 O14757 1/20 0.39
SCN9A Q15858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257776 0.77 KDM4E (0.41) CCR1CCR5CCR8GRM5KDM4E
SCHEMBL30453060 0.77 KDM4E (0.41) CCR1CCR5CCR8GRM5KDM4E
SCHEMBL31030262 0.76 KDM4E (0.48) CCR1CCR5CCR8GRM5KDM4E
SCHEMBL17251975 0.76 KDM4E (0.48) CCR1CCR5CCR8GRM5KDM4E
SCHEMBL25253462 0.76 SCN9A (0.48) CCR1CCR5CCR8GRM5KDM4E
SCHEMBL19065722 0.74 PTGS1 (0.46) PTGS1PTGS2KDM4EPOLBALDH1A1
SCHEMBL18357050 0.70 ERBB2 (0.41) PTGS1PTGS2GRM5KDM4EPOLB
SCHEMBL7576751 0.69 CCR1 (0.53) CCR1CCR5CCR8GRM5KDM4E
SCHEMBL29901533 0.68 CCR1 (0.52) CCR1CCR5CCR8GRM5KDM4E
SCHEMBL28115227 0.68 CCR1 (0.52) CCR1CCR5CCR8GRM5KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544683-B2 Cyclohexyl derivatives HOFFMANN-LA ROCHE INC. (US) 2009-06-09 US disclosed
US-20090005380-A1 CYCLOHEXYL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2009-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005380-A1 CYCLOHEXYL DERIVATIVES HRH3, HRH4, HCAR2 CCR1 434/4885CCR5 470/4885CCR8 1072/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.